首页> 外国专利> Cimetidine A used as histamine H-2 receptor blocker - is a crystallographically pure polymorphic form of N-methyl-(N')-cyano-(N'')-methyl-imidazolyl methylthio-ethyl-guanidine

Cimetidine A used as histamine H-2 receptor blocker - is a crystallographically pure polymorphic form of N-methyl-(N')-cyano-(N'')-methyl-imidazolyl methylthio-ethyl-guanidine

机译:用作组胺H-2受体阻滞剂的西咪替丁A是N-甲基-(N')-氰基-(N'')-甲基咪唑基甲硫基-乙基胍的晶体学纯净多晶型物

摘要

A practically crystallographically pure polymorphic form of cimetidin N-methyl-N'-cyano-N"-(2-((5-methyl-4-imidazolyl)-methylthio)ethy- l)guanidine , (as cimetidin A). (I), has an infrared spectrum (1% on KBr disc) having broad, pronounced (high) peaks at 1400 and 1395cm-1, a narrow pronounced peak at 1205 cm-1 and a narrow peak of av. height at 1155cm-1 and no peak at 1180 cm-1. Practically crystallographically pure indicates that (I) contains 5(3)%, of any other polymorphic form. (I) is administered in unit doses of 50-750mg (pref. 200-600mg), 1-6 times daily to give a pref. daily dosage of 500-1500mg. (I) is usually administered orally but may also be given parenterally or topically.
机译:西咪替丁N-甲基-N'-氰基-N“-(2-(((5-甲基-4-咪唑基)-甲硫基)乙基-1)胍的实用晶体学纯净多晶型,(如西咪替丁A)。(I )具有一个红外光谱(在KBr光盘上为1%),在1400和1395cm-1处具有宽而明显的(高)峰,在1205 cm-1处具有窄而明显的峰,而在1155cm-1和1155cm-1处有一个平均高度的窄峰。在1180 cm-1处无峰,实际上从晶体学上讲纯净的表明(I)包含5(3)%的任何其他多晶型物(I)以50-750mg(优选200-600mg)的单位剂量给药1每天-6次,每天的首选剂量为500-1500mg(I)通常是口服,但也可以胃肠外或局部给药。

著录项

  • 公开/公告号FR2364906A1

    专利类型

  • 公开/公告日1978-04-14

    原文格式PDF

  • 申请/专利权人 SMITH KLINE FRENCH LABORATORIES;

    申请/专利号FR19770027887

  • 发明设计人

    申请日1977-09-15

  • 分类号C07D233/64;A61K31/415;

  • 国家 FR

  • 入库时间 2022-08-22 21:44:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号